In clinical pharmacokinetic studies of tipranavir/ ritonavir in combination with omeprazole (40 mg qd), no clinically important changes in tipranavir/ ritonavir plasma concentrations were observed and thus no tipranavir/ ritonavir dose adjustment is required.